Association between diffuse cerebral MRI lesions and the occurrence and intractableness of West syndrome in tuberous sclerosis complex

We aimed to clarify the association between magnetic resonance imaging (MRI)-lesion patterns, including cortices and white matters, and the development, occurrence, and intractableness of West syndrome in patients with tuberous sclerosis complex (TSC), using visual analysis. We collected data for 44...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Epilepsy & behavior 2020-02, Vol.103 (Pt A), p.106535-106535, Article 106535
Hauptverfasser: Okanishi, Tohru, Fujimoto, Ayataka, Kanai, Sotaro, Sakuma, Satoru, Ito, Susumu, Okanari, Kazuo, Nishimura, Mitsuyo, Masui, Takayuki, Enoki, Hideo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:We aimed to clarify the association between magnetic resonance imaging (MRI)-lesion patterns, including cortices and white matters, and the development, occurrence, and intractableness of West syndrome in patients with tuberous sclerosis complex (TSC), using visual analysis. We collected data for 44 patients with TSC who had undergone brain MRI and developmental evaluation after the ages of 2 and 3 years, respectively. Fluid-attenuated inversion recovery (FLAIR) and T1-weighted images were used to analyze the number of cyst-like tubers, the number of cyst-like subcortical lesions, and the presence of diffuse lesions involving the cortices and white matter. Developmental delays were observed in 28 patients. Nineteen patients had a history of West syndrome. Cyst-like tubers (range: 1–10), cyst-like subcortical lesions (range: 1–4), and diffuse lesions (range: 1–6 areas) were observed in 15, 9, and 14 patients, respectively. In the univariate analyses, all MRI findings were associated with development and/or history of West syndrome. However, in the multivariate analyses, only the diffuse lesion was associated with severe development (p = 0.003) and history of West syndrome (p = 0.012). In the subanalysis of patients with West syndrome, the diffuse lesions were also associated with pharmacological intractableness. Patients with diffuse lesions had a history of West syndrome with sensitivity of 68% and specificity of 96%. Patients with two or more areas of diffuse lesions had history of pharmacologically intractable West syndrome with sensitivity of 89% and specificity of 91%. Diffuse lesions may help to predict the poor neurological outcomes in patients with TSC. •Brain MRI-lesion patterns were associated with neurological outcomes in TSC.•In previous studies, cyst-like tuber was associated with poor neurological outcomes.•In this study, diffuse lesion was the genuine factor associated with neurological outcomes.•Diffuse lesion was associated with history of West syndrome and severe DQ/IQ in TSC.•Diffuse lesion was also associated with pharmacologically intractable West syndrome.
ISSN:1525-5050
1525-5069
DOI:10.1016/j.yebeh.2019.106535